99-002 Ordinance - Laserfiche WebLink

Home Browse Search

33.4 5AMPLE COLLECTION The coliection and testing of the samptes shall be performed onlv by a laboratory and by a pliysician or healih care professional qualified and authorized to administer and determuie the meaning of an_y test results. The laboratory perforxning the test shall be one that is certified by the National lnstitute of Drug Abuse (NIDA). The laboratory chosen must be agreed to between the Association and the Employer. The laboratory used shall also be one whose procedures are periodically tested by NIDA where they analyze unlrnown sainples sent to an independent party. The results of Bmplovee tests shall be made available to the Medical Review Physician. Collectian of blood or urine samples shall be conductad in a manner which provides the highest degree of security for the sample and freedom from adulteraiion. Recognized strict chain of custody procedures must be followed for all samples as set by NIDA. The Association and tlie Employer agree that securiry of the biological urine and blood samples is absotutely necessary, therefore, the Employer agrces that if the security of the sample is compromised in any way, any positive test shall 6e invalid and may not be used for any gurpose. Blood or urine samples will be submitted as per NIDA Standards. Emplayees have the right for Association or legal counsel representatives to be present during the submission of the sample. A split sample shall be reserved in all cases for an independent analysis in the event of a positive test result. All samples must be stored in a scientific acceptable preserved manner as established by NIDA. All positive confirmed samples and related papervvork must be retained by the Iaboratorv for at least sir months or for the duration of any grievance disciplinary action or legal proceedings, whichever is longer. At the conclusion of this period, the papenvork and specimen shall be destroyed. Tests shall be conducted in a manner to ensure that an Emptoyee's legal drug use and diet does not affect the test resutts. 3 33.5 DRUG TESTING The laboratory shall test only for substances and within the limits for the initial and confirmation test as provided within NIDA standards. The initial test shall use an immunoassay wluch meets the requirements of the Food and Ihug Adnvnistration for commercial distribution. Tlie foilowing initiai cutoff levels shall be used when screening specimens to determine whether they are negative for diese five drugs or classes of drugs: Marijuana metabolites 50 ng/rnl Cocaine metabolites 300 ng/ml Opiate metabolites* 300 ngJml Phencyclidine 25 ng/ml AOWI Amphetamines 1,000 ng/ml 38